337 related articles for article (PubMed ID: 34836955)
1. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.
Lapuente D; Fuchs J; Willar J; Vieira Antão A; Eberlein V; Uhlig N; Issmail L; Schmidt A; Oltmanns F; Peter AS; Mueller-Schmucker S; Irrgang P; Fraedrich K; Cara A; Hoffmann M; Pöhlmann S; Ensser A; Pertl C; Willert T; Thirion C; Grunwald T; Überla K; Tenbusch M
Nat Commun; 2021 Nov; 12(1):6871. PubMed ID: 34836955
[TBL] [Abstract][Full Text] [Related]
2. Intranasal administration of unadjuvanted SARS-CoV-2 spike antigen boosts antigen-specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters.
Agbayani G; Akache B; Renner TM; Tran A; Stuible M; Dudani R; Harrison BA; Duque D; Bavananthasivam J; Deschatelets L; Hemraz UD; Régnier S; Durocher Y; McCluskie MJ
Eur J Immunol; 2024 Jun; 54(6):e2350620. PubMed ID: 38561974
[TBL] [Abstract][Full Text] [Related]
3. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Afkhami S; D'Agostino MR; Zhang A; Stacey HD; Marzok A; Kang A; Singh R; Bavananthasivam J; Ye G; Luo X; Wang F; Ang JC; Zganiacz A; Sankar U; Kazhdan N; Koenig JFE; Phelps A; Gameiro SF; Tang S; Jordana M; Wan Y; Mossman KL; Jeyanathan M; Gillgrass A; Medina MFC; Smaill F; Lichty BD; Miller MS; Xing Z
Cell; 2022 Mar; 185(5):896-915.e19. PubMed ID: 35180381
[TBL] [Abstract][Full Text] [Related]
4. Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.
McMahan K; Wegmann F; Aid M; Sciacca M; Liu J; Hachmann NP; Miller J; Jacob-Dolan C; Powers O; Hope D; Wu C; Pereira J; Murdza T; Mazurek CR; Hoyt A; Boon ACM; Davis-Gardner M; Suthar MS; Martinot AJ; Boursiquot M; Cook A; Pessaint L; Lewis MG; Andersen H; Tolboom J; Serroyen J; Solforosi L; Costes LMM; Zahn RC; Barouch DH
Nature; 2024 Feb; 626(7998):385-391. PubMed ID: 38096903
[TBL] [Abstract][Full Text] [Related]
5. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP
Front Immunol; 2021; 12():781280. PubMed ID: 34987509
[TBL] [Abstract][Full Text] [Related]
6. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models.
Zhou R; Wang P; Wong YC; Xu H; Lau SY; Liu L; Mok BW; Peng Q; Liu N; Woo KF; Deng S; Tam RC; Huang H; Zhang AJ; Zhou D; Zhou B; Chan CY; Du Z; Yang D; Au KK; Yuen KY; Chen H; Chen Z
EBioMedicine; 2022 Jan; 75():103762. PubMed ID: 34942445
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.
Bošnjak B; Odak I; Barros-Martins J; Sandrock I; Hammerschmidt SI; Permanyer M; Patzer GE; Greorgiev H; Gutierrez Jauregui R; Tscherne A; Schwarz JH; Kalodimou G; Ssebyatika G; Ciurkiewicz M; Willenzon S; Bubke A; Ristenpart J; Ritter C; Tuchel T; Meyer Zu Natrup C; Shin DL; Clever S; Limpinsel L; Baumgärtner W; Krey T; Volz A; Sutter G; Förster R
Front Immunol; 2021; 12():772240. PubMed ID: 34858430
[TBL] [Abstract][Full Text] [Related]
8. Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice.
Rice A; Verma M; Shin A; Zakin L; Sieling P; Tanaka S; Balint J; Dinkins K; Adisetiyo H; Morimoto B; Higashide W; Anders Olson C; Mody S; Spilman P; Gabitzsch E; Safrit JT; Rabizadeh S; Niazi K; Soon-Shiong P
Sci Rep; 2021 Jul; 11(1):14917. PubMed ID: 34290317
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice.
Yang H; Xie Y; Li S; Bao C; Wang J; Li C; Nie J; Quan Y
Hum Vaccin Immunother; 2024 Dec; 20(1):2364519. PubMed ID: 38880868
[TBL] [Abstract][Full Text] [Related]
10. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules.
Eo SK; Gierynska M; Kamar AA; Rouse BT
J Immunol; 2001 May; 166(9):5473-9. PubMed ID: 11313385
[TBL] [Abstract][Full Text] [Related]
11. Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.
Mao T; Israelow B; Peña-Hernández MA; Suberi A; Zhou L; Luyten S; Reschke M; Dong H; Homer RJ; Saltzman WM; Iwasaki A
Science; 2022 Nov; 378(6622):eabo2523. PubMed ID: 36302057
[TBL] [Abstract][Full Text] [Related]
12. Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice.
Li J; Hsu KS; Howe SE; Hoang T; Xia Z; Berzofsky JA; Sui Y
Front Immunol; 2024; 15():1386243. PubMed ID: 38835757
[TBL] [Abstract][Full Text] [Related]
13. Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques.
Kaiser JA; Nelson CE; Liu X; Park HS; Matsuoka Y; Luongo C; Santos C; Ahlers LRH; Herbert R; Moore IN; Wilder-Kofie T; Moore R; Walker A; Yang L; Munir S; Teng IT; Kwong PD; Dowdell K; Nguyen H; Kim J; Cohen JI; Johnson RF; Garza NL; Via LE; Barber DL; Buchholz UJ; Le Nouën C
Nat Commun; 2024 Apr; 15(1):3553. PubMed ID: 38670948
[TBL] [Abstract][Full Text] [Related]
14. An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Vesin B; Lopez J; Noirat A; Authié P; Fert I; Le Chevalier F; Moncoq F; Nemirov K; Blanc C; Planchais C; Mouquet H; Guinet F; Hardy D; Vives FL; Gerke C; Anna F; Bourgine M; Majlessi L; Charneau P
Mol Ther; 2022 Sep; 30(9):2984-2997. PubMed ID: 35484842
[TBL] [Abstract][Full Text] [Related]
15. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
[TBL] [Abstract][Full Text] [Related]
16. Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice.
Li X; Wang L; Liu J; Fang E; Liu X; Peng Q; Zhang Z; Li M; Liu X; Wu X; Zhao D; Yang L; Li J; Cao S; Huang Y; Shi L; Xu H; Wang Y; Suo Y; Yue G; Nie J; Huang W; Li W; Li Y
Emerg Microbes Infect; 2022 Dec; 11(1):1890-1899. PubMed ID: 35775819
[TBL] [Abstract][Full Text] [Related]
17. Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Ku MW; Bourgine M; Authié P; Lopez J; Nemirov K; Moncoq F; Noirat A; Vesin B; Nevo F; Blanc C; Souque P; Tabbal H; Simon E; Hardy D; Le Dudal M; Guinet F; Fiette L; Mouquet H; Anna F; Martin A; Escriou N; Majlessi L; Charneau P
Cell Host Microbe; 2021 Feb; 29(2):236-249.e6. PubMed ID: 33357418
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.
Liu H; Patil HP; de Vries-Idema J; Wilschut J; Huckriede A
PLoS One; 2013; 8(7):e69649. PubMed ID: 23936066
[TBL] [Abstract][Full Text] [Related]
19. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.
Del Fresno C; García-Arriaza J; Martínez-Cano S; Heras-Murillo I; Jarit-Cabanillas A; Amores-Iniesta J; Brandi P; Dunphy G; Suay-Corredera C; Pricolo MR; Vicente N; López-Perrote A; Cabezudo S; González-Corpas A; Llorca O; Alegre-Cebollada J; Garaigorta U; Gastaminza P; Esteban M; Sancho D
Front Immunol; 2021; 12():748103. PubMed ID: 34867974
[TBL] [Abstract][Full Text] [Related]
20. A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine.
Li X; Peng Q; Liu X; Xu H; Liu J; Wu X; Ye Q; Li M; Li Y
Front Immunol; 2024; 15():1374486. PubMed ID: 38745651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
